Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Recurrence of Bladder Cancer After Transurethral Resection With Hexvix

NCT00785694 is registered in ClinicalTrials.gov with GE Healthcare as lead sponsor.

NCT NCT00785694
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00785694 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Recurrence of Bladder Cancer After Transurethral Resection With Hexvix
Lead sponsor
GE Healthcare
Phase
Phase 4
Overall status
Withdrawn
Start date
December 31, 2008
Completion date
August 31, 2011
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer